Dai-ichi Life Insurance Company
LIN icon

Dai-ichi Life Insurance Company’s Linde LIN Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio LIN Stock Details LIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3M Buy
48,753
+4,378
+10% +$2.22M 0.59% 38
2026
Q1 		$22M Sell
44,375
-3,184
-7% -$1.5M 0.63% 37
2025
Q4 		$20.3M Sell
47,559
-4,880
-9% -$2.09M 0.52% 44
2025
Q3 		$24.9M Buy
52,439
+6,152
+13% +$2.91M 0.62% 39
2025
Q2 		$21.7M Sell
46,287
-1,087
-2% -$496K 0.61% 36
2025
Q1 		$22.1M Sell
47,374
-143
-0.3% -$64.4K 0.64% 42
2024
Q4 		$19.9M Sell
47,517
-12,706
-21% -$5.79M 0.55% 42
2024
Q3 		$28.7M Sell
60,223
-3,420
-5% -$1.56M 0.73% 31
2024
Q2 		$27.9M Sell
63,643
-215
-0.3% -$94.6K 0.68% 31
2024
Q1 		$29.7M Sell
63,858
-4,165
-6% -$1.8M 0.67% 30
2023
Q4 		$27.9M Sell
68,023
-1,055
-2% -$416K 0.58% 39
2023
Q3 		$25.7M Buy
69,078
+24,529
+55% +$9.34M 0.57% 37
2023
Q2 		$17M Buy
44,549
+11,883
+36% +$4.34M 0.35% 60
2023
Q1 		$11.6M Buy
32,666
+2,188
+7% +$733K 0.25% 82
2022
Q4 		$9.9M Buy
30,478
+870
+3% +$273K 0.23% 91
2022
Q3 		$7.98M Sell
29,608
-5,894
-17% -$1.69M 0.2% 103
2022
Q2 		$10.2M Buy
35,502
+9,151
+35% +$2.86M 0.23% 92
2022
Q1 		$8.42M Sell
26,351
-5,000
-16% -$1.55M 0.13% 151
2021
Q4 		$10.9M Sell
31,351
-10,000
-24% -$3.24M 0.14% 131
2021
Q3 		$12.1M Sell
41,351
-5,536
-12% -$1.68M 0.16% 119
2021
Q2 		$13.6M Sell
46,887
-779
-2% -$227K 0.17% 110
2021
Q1 		$13.4M Buy
47,666
+10,454
+28% +$2.71M 0.18% 95
2020
Q4 		$9.8M Sell
37,212
-95
-0.3% -$23.3K 0.14% 117
2020
Q3 		$8.88M Sell
37,307
-225
-0.6% -$54.6K 0.16% 110
2020
Q2 		$7.96M Sell
37,532
-1,111
-3% -$215K 0.18% 100
2020
Q1 		$6.68M Hold
38,643
– – 0.26% 96
2019
Q4 		$8.23M Buy
38,643
+237
+0.6% +$47.8K 0.19% 123
2019
Q3 		$7.44M Hold
38,406
– – 0.18% 133
2019
Q2 		$7.71M Buy
38,406
+97
+0.3% +$18.1K 0.19% 126
2019
Q1 		$6.74M Sell
38,309
-317
-0.8% -$52.7K 0.17% 134
2018
Q4 		$6.03M Buy
+38,626
New +$6.1M 0.16% 145

Other funds holding LIN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dai-ichi Life Insurance Company's LIN Position: Q2 2026 in Review

Dai-ichi Life Insurance Company increased its Linde (LIN) stake by 9.9% in Q2 2026, buying an estimated $2.22M and bringing the position to 48,753 shares worth $25.3M. The position accounts for 0.59% of the portfolio, ranked #38.

Dai-ichi Life Insurance Company first reported a position in LIN in Q4 2018 and has held it in 31 quarters since. The position peaked at $29.7M in Q1 2024. 2,352 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Dai-ichi Life Insurance Company held 48,753 shares of Linde worth $25.3M as of Q2 2026.
  • Dai-ichi Life Insurance Company bought 4,378 Linde shares in Q2 2026, an estimated $2.22M.
  • Linde made up 0.59% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #38 holding.
  • Dai-ichi Life Insurance Company first reported a position in Linde in Q4 2018 and has held it in 31 quarters since.
  • Dai-ichi Life Insurance Company's Linde position peaked at $29.7M in Q1 2024.
  • 2,352 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.